Efficacy of adalimumab therapy in patients with Crohn's disease who were unresponsive to or intolerant of infliximab: 6 years of experience in a single gastroenterology center.

被引：0
|
作者：
Shafran, I [1 ]
Cangemi, D. [1 ]
Burgunder, P. [1 ]
机构：
[1] Shafran Gastroenterol Ctr, Winter Pk, FL USA
来源：
INFLAMMATORY BOWEL DISEASES | 2011年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S62 / S63
页数：2
相关论文
共 50 条
  • [1] Efficacy of Adalimumab Therapy in Patients with Crohn's Disease Who Were Unresponsive to or Intolerant of Infliximab: Six Years of Experience in a Single Gastroenterology Center
    Shafran, Ira
    Cangemi, David
    Burgunder, Patricia
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S444 - S444
  • [2] Adalimumab Therapy for Patients With Crohn's Disease Who Are Unresponsive to or Intolerant of Infliximab
    Shafran, I
    Burgunder, P.
    Fakih, A.
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (12) : S44 - S44
  • [3] Clinical experience with infliximab and adalimumab in a single-center cohort of patients with Crohn's disease
    Riis, Ase
    Martinsen, Tom C.
    Waldum, Helge L.
    Fossmark, Reidar
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2012, 47 (06) : 649 - 657
  • [4] Open label experience with adalimumah in pediatric Crohn's disease patients who lost response or were intolerant to infliximab
    Deslandres, Colette
    Faure, Christophe
    Dirks, Martha H.
    Gervais, France
    Seidman, Ernest G.
    GASTROENTEROLOGY, 2006, 130 (04) : A656 - A656
  • [5] Remission and clinical response to adalimumab at 4 weeks in patients with active luminal Crohn's disease who had lost response to or were intolerant of infliximab therapy
    Hinojosa, Joaquin
    Garcia, S.
    Esteve, M.
    Garcia, V.
    Martinez, P.
    Obrador, A.
    Gassull, M. A.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S455 - S456
  • [6] Efficacy of adalimumab as second-line therapy in a pediatric cohort of Crohn's disease patients who failed infliximab therapy: the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition experience
    Alvisi, Patrizia
    Arrigo, Serena
    Cucchiara, Salvatore
    Lionetti, Paolo
    Miele, Erasmo
    Romano, Claudio
    Ravelli, Alberto
    Knafelz, Daniela
    Martelossi, Stefano
    Guariso, Graziella
    Accomando, Salvatore
    Zuin, Giovanna
    De Giacomo, Costantino
    Balzani, Lucio
    Gennari, Monia
    Aloi, Marina
    BIOLOGICS-TARGETS & THERAPY, 2019, 13 : 13 - 21
  • [7] The Safety and Efficacy of Adalimumab in Patients with Crohn's Disease: The Experience of a Single Tertiary Care Center
    Teriaky, Anouar
    Mosli, Mahmoud
    Gregor, Jamie
    Yan, Brian
    Ponich, Terry
    Chande, Nilesh
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S512 - S512
  • [8] Adalimumab is effective in patients with fistulizing Crohn's disease who were primary nonresponders to infliximab treatment
    Lichtiger, Simon
    Binion, David
    Wolf, Douglas
    Present, Daniel
    Lomax, Kathleen
    Rafiq, Shuvobrata
    Holdbrook, Fred
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S416 - S416
  • [9] Efficacy of adalimumab in patients with Crohn's disease and failure to infliximab therapy: a clinical series
    Cordero Ruiz, Patricia
    Castro Marquez, Cristina
    Mendez Rufian, Vanesa
    Castro Laria, Luisa
    Caunedo Alvarez, Angel
    Romero Vazquez, Javier
    Herrerias Gutierrez, Juan Manuel
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2011, 103 (06) : 294 - 298
  • [10] Efficacy of biosimilar infliximab induction therapy in paediatric patients with Crohn's disease: 1.5 years of experience
    Sieczkowska, J.
    Plocek, A.
    Banaszkiewicz, A.
    Jarzebicka, D.
    Gawronska, A.
    Toporowska-Kowalska, E.
    Kierkus, J.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S369 - S370
12345